Study guide

3.1 Classification & Diagnosis of Hypertensive Disorders of Pregnancy

AMCB Certified Nurse-Midwife CNM

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Early Pregnancy — Diagnosis, History, Dating & Models of Care

1.1 Signs of Pregnancy, hCG Kinetics & Acceptance of Pregnancy 1.2 Prenatal History, Obstetric Notation & Gestational Dating 1.3 The Initial Prenatal Laboratory Panel 1.4 Prenatal Genetic Screening, Diagnostic Testing & Hereditary Risk 1.5 Models of Prenatal Care, Birth-Setting Counseling & Community Referral

2 Chapter 2: Ongoing Prenatal Assessment, Nutrition & Common Discomforts

2.1 Prenatal Visit Cadence, Milestone Screening & Fundal Height 2.2 Leopold Maneuvers, Fetal Heart Auscultation & Antepartum Surveillance 2.3 Clinical Pelvimetry & Assessment of the Bony Pelvis 2.4 Maternal Nutrition, Weight Gain & Immunization in Pregnancy 2.5 Nausea, Vomiting & Gastrointestinal Discomforts of Pregnancy 2.6 Musculoskeletal, Vascular & Neurologic Discomforts of Pregnancy

3 Chapter 3: Hypertensive, Endocrine & Hematologic Complications of Pregnancy

3.1 Classification & Diagnosis of Hypertensive Disorders of Pregnancy 3.2 Acute Severe Hypertension, Magnesium Sulfate & Eclampsia 3.3 Delivery Timing, Aspirin Prophylaxis & Postpartum Hypertension 3.4 Gestational Diabetes: Pathophysiology, Screening & Diagnosis 3.5 Glycemic Management, Fetal Surveillance & Delivery Timing in Gestational Diabetes 3.6 Thyroid Disorders & Anemia in Pregnancy

4 Chapter 4: Bleeding, Amniotic Fluid Disorders, Preterm Birth & Perinatal Loss

4.1 First-Trimester Bleeding, Early Pregnancy Loss & Gestational Trophoblastic Disease 4.2 Ectopic Pregnancy: Diagnosis & Management 4.3 Third-Trimester Bleeding & Amniotic Fluid Volume Disorders 4.4 Preterm Labor & Preterm Prelabor Rupture of Membranes 4.5 Intrauterine Fetal Demise, Stillbirth & Bereavement Care

5 Chapter 5: Normal Labor, Birth & Intrapartum Fetal Surveillance

5.1 Onset of Labor, True Versus False Labor & Nutrition in Labor 5.2 The First and Second Stages of Labor 5.3 Cardinal Movements, Third & Fourth Stages of Labor 5.4 Cord Clamping, Cord Blood, Cord Gases & Placental Examination 5.5 Fetal Oxygenation, Intermittent Auscultation & Uterine Activity Monitoring 5.6 Electronic Fetal Monitoring Parameters & the NICHD Categories 5.7 Intrauterine Resuscitation, Scalp Electrode & Amnioinfusion

6 Chapter 6: Labor Support, Analgesia, Induction & Augmentation

6.1 The Midwifery Model, Continuous Labor Support & Non-Pharmacologic Comfort 6.2 Water Immersion, Waterbirth & Non-Supine Birth Positions 6.3 Systemic, Neuraxial & Regional Analgesia in Labor 6.4 Indications & Timing for Induction of Labor 6.5 The Bishop Score & Cervical Ripening Methods 6.6 Oxytocin Titration, Tachysystole Management & Amniotomy

7 Chapter 7: Intrapartum Emergencies, Malpresentation & Perineal Repair

7.1 Shoulder Dystocia: Recognition & the HELPERR Protocol 7.2 Dystocia Complications, Umbilical Cord Prolapse & Intraamniotic Infection 7.3 Malposition, Manual Rotation, Breech, Face Presentation & Nuchal Cord 7.4 Perineal Anatomy & Classification of Obstetric Lacerations 7.5 Episiotomy & Surgical Perineal Repair 7.6 TOLAC, VBAC & Uterine Rupture

8 Chapter 8: The Normal Puerperium, Postpartum Assessment & Lactation

8.1 Puerperal Physiology, Uterine Involution & Lochia 8.2 The BUBBLE-HE Postpartum Assessment 8.3 Bladder, Bowel & Perineal Care and the Postpartum Care Continuum 8.4 Lactation Neuroendocrinology & the Stages of Lactogenesis 8.5 LATCH Assessment, Latch Biomechanics & Adequate Intake 8.6 Lactation Complications, Medication Safety & Contraindications

9 Chapter 9: Postpartum Contraception, Family Planning & Hemorrhage

9.1 Return of Fertility, Lactational Amenorrhea & US MEC in the Puerperium 9.2 Postpartum Hormonal Contraception & Intrauterine Devices 9.3 Barrier & Permanent Contraception, Postpartum Sexuality & Family Support 9.4 Postpartum Hemorrhage: Definition, Shock Recognition & Quantitative Blood Loss 9.5 The Four Ts: Etiology of Postpartum Hemorrhage 9.6 Hemorrhage Resuscitation, Uterotonics, TXA & Surgical Escalation

10 Chapter 10: Puerperal Infection, Thromboembolism, Cesarean Recovery & Perinatal Mental Health

10.1 Puerperal Endometritis & Septic Pelvic Thrombophlebitis 10.2 Puerperal Wound Infection, Mastitis & Breast Abscess 10.3 Postpartum Venous Thromboembolism 10.4 Post-Cesarean Recovery: Inpatient Care & Care After Discharge 10.5 Postpartum Blues, Depression & EPDS Screening 10.6 Treating Postpartum Depression, Anxiety, OCD & Psychosis

11 Chapter 11: Neonatal Transition, Resuscitation & the Newborn Examination

11.1 Fetal-to-Neonatal Transition & Circulatory Remodeling 11.2 APGAR Scoring & the NRP Initial Steps 11.3 Positive Pressure Ventilation, MR. SOPA & Advanced Resuscitation 11.4 Newborn Vital Signs, Anthropometrics & the Ballard Score 11.5 Cranial Assessment & Head-to-Chest Examination 11.6 Genitourinary & Musculoskeletal Examination and Primitive Reflexes

12 Chapter 12: Newborn Prophylaxis, Screening, Common Disorders & Care Through 28 Days

12.1 Standard Neonatal Prophylaxis: Vitamin K, Eye Ointment & Hepatitis B 12.2 Universal Newborn Screening: Hearing, CCHD & Dried Blood Spot 12.3 Neonatal Hypoglycemia, Thermoregulation & the Infant of a Diabetic Mother 12.4 Neonatal Hyperbilirubinemia & Phototherapy 12.5 Infant Feeding Education, Circumcision Counseling & Care Through 28 Days

13 Chapter 13: Well-Woman Preventive Care, Cancer Screening & Immunization

13.1 The Well-Woman Visit & Cervical Cancer Screening 13.2 ASCCP Risk-Based Management & Breast Cancer Screening 13.3 Colorectal Cancer & Osteoporosis Screening 13.4 Adult Immunization & Environmental and Occupational Exposure Screening

14 Chapter 14: Contraception, Abortion Care & Fertility Evaluation

14.1 Contraceptive Efficacy Tiers & Long-Acting Reversible Contraception 14.2 Combined Hormonal Contraception 14.3 Progestin-Only Methods & Emergency Contraception 14.4 Abortion Care: Options Counseling, Medication Abortion & Follow-Up 14.5 Initial Infertility Evaluation & Gynecologic Imaging Referral

15 Chapter 15: Benign Gynecologic Conditions, Pelvic Floor & Menstrual Disorders

15.1 Endometriosis & Adenomyosis 15.2 Pelvic Organ Prolapse & Urinary Incontinence 15.3 Adnexal Masses, Malignancy Red Flags & Vulvar Disease 15.4 The Normal Menstrual Cycle & Anticipatory Guidance 15.5 The FIGO PALM-COEIN Classification of Abnormal Uterine Bleeding 15.6 Evaluating Abnormal Uterine Bleeding & the Amenorrhea Workup 15.7 Polycystic Ovary Syndrome

16 Chapter 16: Vaginitis, Sexually Transmitted Infections, Sexual Health & Menopause

16.1 Differential Diagnosis of Vaginitis & Bacterial Vaginosis 16.2 Candidiasis, Trichomoniasis, Chlamydia & Gonorrhea 16.3 Pelvic Inflammatory Disease 16.4 Genital Herpes, Syphilis & Anogenital Warts 16.5 Sexual Health Assessment, Sexual Function & Care After Sexual Assault 16.6 Reproductive Aging, Menopause Definitions & Clinical Manifestations 16.7 Menopausal Hormone Therapy 16.8 Non-Hormonal Therapies & Postmenopausal Osteoporosis

17 Chapter 17: Primary Care — Chronic Disease & Common Acute Conditions

17.1 Midwifery Primary Care Scope & Hypertension Management 17.2 Antihypertensive Pharmacotherapy & Hyperlipidemia 17.3 Type 2 Diabetes & Thyroid Disease in Primary Care 17.4 Respiratory Infections, Asthma & Urinary Tract Infection 17.5 Gastrointestinal & Dermatologic Conditions 17.6 Mental Health Screening & Substance Use Disorders 17.7 Intimate Partner Violence, Reproductive Coercion & Human Trafficking

18 Chapter 18: Midwifery Scope of Practice, Ethics, Collaboration & Health Equity

18.1 Regulatory Foundation of Practice & the Midwifery Model of Care 18.2 Bioethics, Informed Refusal & Collaborative Practice 18.3 Maternal Health Disparities, Structural Racism & Inclusive Care

3.1 Classification & Diagnosis of Hypertensive Disorders of Pregnancy

Key Takeaways Explain This Topic AI

Proteinuria is no longer required to diagnose preeclampsia when new-onset hypertension after 20 weeks is accompanied by thrombocytopenia below 100,000/uL, transaminases twice the upper limit of normal, creatinine above 1.1 mg/dL, pulmonary edema, or persistent cerebral or visual symptoms.

The CHAP trial established a blood pressure target below 140/90 mmHg for mild chronic hypertension in pregnancy, replacing the historical 160/105 mmHg threshold, without impairing fetal growth.

ACE inhibitors, angiotensin receptor blockers, direct renin inhibitors, and mineralocorticoid receptor antagonists are contraindicated throughout pregnancy because of fetal renal dysgenesis, oligohydramnios sequence, and calvarial hypoplasia.

Massive proteinuria greater than 5 g per 24 hours and fetal growth restriction were deliberately removed from the severe-features criteria in contemporary guidelines.

Up to 15 to 20 percent of patients with HELLP syndrome have neither hypertension nor proteinuria, making LDH above 600 IU/L, transaminases twice normal, and platelets below 100,000/uL the diagnostic anchors.

Last updated: September 2026

Hypertensive disorders complicate approximately 8% to 10% of all pregnancies worldwide and remain a leading cause of maternal and perinatal morbidity and mortality. For the Certified Nurse-Midwife (CNM), precise differentiation between chronic hypertension, gestational hypertension, preeclampsia, eclampsia, and HELLP syndrome is fundamental to antepartum risk stratification, collaborative practice, and timely intervention.

Diagnostic Classification of Hypertensive Disorders in Pregnancy

The American College of Obstetricians and Gynecologists (ACOG) and the American College of Nurse-Midwives (ACNM) classify hypertensive disorders into five major clinical categories based on gestational age at onset, the presence of proteinuria, and end-organ systemic involvement.

Classification Onset Timing Blood Pressure Thresholds Diagnostic Hallmarks & End-Organ Criteria Postpartum Resolution

Chronic Hypertension Pre-pregnancy or <20 weeks gestation SBP ≥140 mmHg or DBP ≥90 mmHg Present before conception or diagnosed prior to 20 0/7 weeks; no new proteinuria Persists beyond 12 weeks postpartum

Gestational Hypertension ≥20 0/7 weeks gestation SBP ≥140 mmHg or DBP ≥90 mmHg (2 checks, ≥4h apart) Absence of proteinuria and absence of severe systemic features Typically normalizes by 12 weeks postpartum

Preeclampsia without Severe Features ≥20 0/7 weeks gestation SBP ≥140 mmHg or DBP ≥90 mmHg (2 checks, ≥4h apart) Proteinuria: ≥300 mg/24h urine, uPCR ≥0.3 mg/mg, or dipstick 2+ Normalizes within days to weeks postpartum

Preeclampsia with Severe Features ≥20 0/7 weeks gestation (or postpartum) SBP ≥160 mmHg or DBP ≥110 mmHg (confirmed ≥15 min apart) OR mild BP with severe features Severe BP OR thrombocytopenia (<100k), liver enzymes ≥2x ULN, severe RUQ pain, Cr >1.1 mg/dL, pulmonary edema, persistent cerebral/visual symptoms Variable resolution; high risk for postpartum recurrence

Eclampsia Antepartum, intrapartum, or postpartum Variable; frequently severe but may be mild New-onset generalized grand mal tonic-clonic seizures in a woman with preeclampsia not attributable to other causes Seizures cease after delivery and magnesium therapy

HELLP Syndrome Typically 27w to postpartum (peak 32–34w) Often elevated, but 15% have normal/mild BPs Microangiopathic hemolytic anemia, AST/ALT ≥2x ULN, thrombocytopenia (<100,000/μL) Nadir of platelets at 24–48h postpartum, then resolves

  • Deep-Dive Clinical Criteria & Pathophysiology
  • Chronic Hypertension and Superimposed Preeclampsia

Chronic hypertension is defined as high blood pressure documented prior to pregnancy or before 20 weeks gestation, or hypertension that was initially diagnosed during pregnancy but persists beyond 12 weeks postpartum.

Contemporary Management (CHAP Trial Update): In accordance with the Chronic Hypertension and Pregnancy (CHAP) trial findings, treatment of mild chronic hypertension to a blood pressure target of <140/90 mmHg (rather than the historical threshold of 160/105 mmHg) significantly reduces the incidence of superimposed preeclampsia, preterm birth, placental abruption, and cardiovascular complications without impairing fetal growth.

Preferred First-Line Oral Agents: Oral labetalol (100–400 mg twice to three times daily), extended-release nifedipine (30–90 mg once daily), and methyldopa (250–500 mg two to three times daily).

Absolute Contraindications: Angiotensin-converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs), direct renin inhibitors, and mineralocorticoid receptor antagonists are strictly contraindicated throughout pregnancy due to risks of fetal renal dysgenesis, oligohydramnios sequence, pulmonary hypoplasia, calvarial hypoplasia, and intrauterine fetal demise.

Superimposed Preeclampsia: Occurs in 20% to 50% of women with chronic hypertension. Diagnosed when there is a sudden, refractory escalation in baseline blood pressure, new onset of proteinuria in a woman previously without it, a dramatic sudden increase in baseline proteinuria, or the emergence of any systemic severe features (thrombocytopenia, hepatic transaminitis, renal insufficiency, or neurologic symptoms).

Preeclampsia Diagnostic Criteria: The Modern Paradigm

Historically, proteinuria was mandatory for the diagnosis of preeclampsia. Current diagnostic guidelines recognize that preeclampsia is a multisystem endothelial disorder; therefore, proteinuria is no longer required if other systemic manifestations are present.

In a woman with new-onset hypertension after 20 weeks gestation (SBP ≥140 mmHg or DBP ≥90 mmHg on two occasions at least 4 hours apart), preeclampsia is established if any of the following criteria are met:

Proteinuria:

  • ≥300 mg per 24-hour urine collection (gold standard), OR
  • Urine protein-to-creatinine ratio ( uPCR ) ≥0.3 mg/mg (or ≥30 mg/mmol), OR

Urine dipstick reading of 2+ or greater (used only if quantitative methods are unavailable).

Thrombocytopenia: Platelet count <100,000/μL.

Renal Insufficiency: Serum creatinine concentration >1.1 mg/dL, or a doubling of the baseline serum creatinine in the absence of other intrinsic renal disease.

Impaired Liver Function: Elevated blood concentrations of liver transaminases (alanine aminotransferase [ALT] or aspartate aminotransferase [AST]) to twice the upper limit of normal, or severe persistent right upper quadrant or epigastric pain unresponsive to medication and not accounted for by alternative diagnoses.

Pulmonary Edema: Clinical and radiographic evidence of alveolar fluid accumulation.

New-Onset Headache and Visual Symptoms: Persistent, severe, throbbing headache unresponsive to standard analgesics (e.g., acetaminophen) and visual scotomata, photopsia, diplopia, or cortical blindness.

Midwifery Pearl: Massive proteinuria (historically defined as >5 grams/24 hours) and fetal growth restriction (FGR) have been deliberately removed from the diagnostic criteria for severe features in contemporary guidelines. While massive proteinuria warrants clinical vigilance, it does not by itself dictate immediate delivery in the absence of other severe features.

HELLP Syndrome

HELLP syndrome represents a severe, life-threatening variant of preeclampsia characterized by microangiopathic hemolytic anemia, hepatic necrosis, and profound consumptive thrombocytopenia. Up to 15% to 20% of patients with HELLP syndrome do not exhibit antecedent hypertension or overt proteinuria, presenting a major diagnostic pitfall.

Hemolysis (H): Microangiopathic hemolysis demonstrated by abnormal peripheral blood smear with schistocytes, helmet cells, or burr cells; elevated total bilirubin (≥1.2 mg/dL, primarily indirect); low or undetectable serum haptoglobin (<25 mg/dL); and markedly elevated serum lactate dehydrogenase ( LDH >600 IU/L ).

Elevated Liver Enzymes (EL): Serum AST or ALT elevated to at least twice the upper limit of institutional normal (typically AST ≥70 IU/L), reflecting periportal sinusoidal fibrin deposition and hepatocellular necrosis.

Low Platelets (LP): Platelet count <100,000/μL (Mississippi Class 1: <50,000/μL; Class 2: 50,000–100,000/μL; Class 3: 100,000–150,000/μL).

Complications: Subcapsular liver hematoma, hepatic rupture, disseminated intravascular coagulation (DIC; present in 20%), placental abruption, acute renal failure, and pulmonary edema.

Loading diagram... Hypertensive Disorders in Pregnancy Diagnostic & Triage Algorithm